This study is looking at how a device called NeuroCuple™ might help manage pain after a cesarean delivery (C-section). Researchers want to see if women who use the NeuroCuple device need less opioid pain medication compared to those who receive standard care. The NeuroCuple device is placed around the abdomen over C-section bandages. You might be able to join if you are a woman aged 18 or older, are having a planned or unplanned C-section, and have intact skin around the incision area. The study will measure the total amount of opioid pain medication you use from the day of surgery until four days after. The current recruitment status is unclear.

Study design

This is a randomized study with 180 participants, meaning you would be randomly assigned to one of three groups: the active device, a sham device (looks like the active device but doesn't work), or standard care. Both you and the medical team would not know if you received the active or sham device.

What's involved

If you join, the device would be placed in the recovery room after your C-section. Your pain scores would be collected while you are in the hospital and daily after you go home until four days after surgery.

Compensation

Not stated in the trial record.

Follow-up

Your pain medication use will be tracked from the day of surgery until four days after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.